http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
A Soluble ‘Ba(Ni-ett)’ (ett = 1,1,2,2-ethenetetrathiolate) Derived Thermoelectric Material
Yaoyang Hu,Geoffrey Rivers,Michael P. Weir,David B. Amabilino,Christopher J. Tuck,Ricky D. Wildman,Oleg Makarovsky,Simon Woodward 대한금속·재료학회 2024 ELECTRONIC MATERIALS LETTERS Vol.20 No.2
We describe the synthesis and characterisation of the fi rst of a new class of soluble ladder oligomeric thermoelectric materialbased on previously unutilised ethene-1,1,2,2-tetrasulfonic acid. Reaction of Ba(OH) 2 and propionic acid at a 1:1 stoichiometryleads to the formation of the previously unrecognised soluble [Ba(OH)(O 2 CEt)] H 2 O. The latter when used to hydrolyse1,3,4,6-tetrathiapentalene-2,5-dione (TPD), in the presence of NiCl 2 , forms a new material whose elemental compositionis in accord with the formula [(EtCO 2 Ba) 4 Ni 8 {(O 3 S) 2 C = C(SO 3 ) 2 } 5 ] 22H 2 O ( 4 ). Compound 4 can be pressed into pellets,drop-cast as DMSO solutions or ink-jet printed (down to sub-mm resolutions). While its room temperature thermoelectricproperties are modest (σ max 0.04 S cm −1 and Seebeck coeffi cient, α max − 25.8 μV K −1 ) we introduce a versatile new oligomericmaterial that opens new possible synthetic routes for n-type thermoelectrics.
Choe, S.w.,Terman, D.S.,Rivers, A.E.,Rivera, J.,Lottenberg, R.,Sorg, B.S. Elsevier Science Publishers 2013 Journal of controlled release Vol.171 No.2
Selective drug delivery to hypoxic tumor niches remains a significant therapeutic challenge that calls for new conceptual approaches. Sickle red blood cells (SSRBCs) have shown an ability to target such hypoxic niches and induce tumoricidal effects when used together with exogenous pro-oxidants. Here we determine whether the delivery of a model therapeutic encapsulated in murine SSRBCs can be enhanced by ex vivo photosensitization under conditions that delay autohemolysis to a time that coincides with maximal localization of SSRBCs in a hypoxic tumor. Hyperspectral imaging of 4T1 carcinomas shows oxygen saturation levels <10% in a large fraction (commonly 50% or more) of the tumor. Using video microscopy of dorsal skin window chambers implanted with 4T1 tumors, we demonstrate that allogeneic SSRBCs, but not normal RBCs (nRBCs), selectively accumulate in hypoxic 4T1 tumors between 12 and 24h after systemic administration. We further show that ex vivo photo-oxidation can program SSRBCs to postpone hemolysis/release of a model therapeutic to a point that coincides with their maximum sequestration in hypoxic tumor microvessels. Under these conditions, drug-loaded photosensitized SSRBCs show a 3-4 fold greater drug delivery to tumors compared to non-photosensitized SSRBCs, drug-loaded photosensitized nRBCs, and free drug. These results demonstrate that photo-oxidized SSRBCs, but not photo-oxidized nRBCs, sequester and hemolyze in hypoxic tumors and release substantially more drug than photo-oxidized nRBCs and non-photo-oxidized SSRBCs. Photo-oxidation of drug-loaded SSRBCs thus appears to exploit the unique tumor targeting and carrier properties of SSRBCs to optimize drug delivery to hypoxic tumors. Such programmed and drug-loaded SSRBCs therefore represent a novel and useful tool for augmenting drug delivery to hypoxic solid tumors.